YM Biosciences
9B07N010
-
- 1,99 €
-
- 1,99 €
Beschreibung des Verlags
The chairman and chief executive officer (CEO) of Ontario-based YM Biosciences (YM), was preparing for the upcoming board meeting. During this meeting several items of strategic importance would be discussed. Two potential acquisitions were being contemplated. In order to prepare for this meeting, the chairman would have to assess the strategic impact of each of the potential acquisitions and the way in which the acquisitions should be conducted.
GENRE
Business und Finanzen
ERSCHIENEN
2008
6. März
SPRACHE
EN
Englisch
UMFANG
17
Seiten
VERLAG
Richard Ivey School of Business Foundation
ANBIETERINFO
Ivey Business School Foundation Foundation
GRÖSSE
2,3
MB
An Analysis of the Initial Adoption of FAS 141 and 142 in the Pharmaceutical Industry.
2006
Pharmaxis: A Star Performer at Commercialization Crossroads
2006
Accounting at Biovail
2004
Grace Bioremediation Technologies
2005
Diabetogen
2000
Ing Renault F1 Team Chooses Appro Xtreme-X Supercomputer
2008